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RESEARCH ARTICLE
Fat4-Dchs1 signalling controls cell proliferation in developing
vertebrae
Anna Kuta1,*, Yaopan Mao2,*, Tina Martin1, Catia Ferreira de Sousa1, Danielle Whiting1, Sana Zakaria1,
Ivan Crespo-Enriquez1, Philippa Evans1, Bartosz Balczerski1, Baljinder Mankoo3, Kenneth D. Irvine2 and
Philippa H. Francis-West1,*,‡
ABSTRACT
The protocadherins Fat4 and Dchs1 act as a receptor-ligand pair to
regulate many developmental processes in mice and humans,
including development of the vertebrae. Based on conservation of
function between Drosophila and mammals, Fat4-Dchs1 signalling
has been proposed to regulate planar cell polarity (PCP) and activity
of the Hippo effectors Yap and Taz, which regulate cell proliferation,
survival and differentiation. There is strong evidence for Fat regulation
of PCP in mammals but the link with the Hippo pathway is unclear.
In Fat4−/− and Dchs1−/− mice, many vertebrae are split along the
midline and fused across the anterior-posterior axis, suggesting that
these defects might arise due to altered cell polarity and/or changes
in cell proliferation/differentiation. We show that the somite and
sclerotome are specified appropriately, the transcriptional network
that drives early chondrogenesis is intact, and that cell polarity within
the sclerotome is unperturbed. We find that the key defect in Fat4 and
Dchs1mutant mice is decreased proliferation in the early sclerotome.
This results in fewer chondrogenic cells within the developing
vertebral body, which fail to condense appropriately along the
midline. Analysis of Fat4;Yap and Fat4;Taz double mutants, and
expression of their transcriptional target Ctgf, indicates that Fat4-
Dchs1 regulates vertebral development independently of Yap and
Taz. Thus, we have identified a new pathway crucial for the
development of the vertebrae and our data indicate that novel
mechanisms of Fat4-Dchs1 signalling have evolved to control cell
proliferation within the developing vertebrae.
KEY WORDS: Fat4, Dchs1, Vertebrae, Somite, Chondrocyte, Yap1,
Taz (Wwtr1), Mouse
INTRODUCTION
Fat4 and Dchs1 are protocadherins that act as a receptor-ligand pair
to play key roles during embryonic development. Gene inactivation
of either Fat4 or Dchs1 in mice results in a wide spectrum of
phenotypes ranging from branching and cystic defects in the kidney,
altered neuronal proliferation and migration, to a change in sternum
shape (Saburi et al., 2008, 2012; Mao et al., 2011, 2015, 2016;
Zakaria et al., 2014; Bagherie-Lachidan et al., 2015; Badouel et al.,
2015). FAT4 and DCHS1 are also essential in humans, and
compound mutations result in Van Maldergem syndrome, which is
characterised, in part, by intellectual disability and altered
craniofacial development (Cappello et al., 2013); in some
individuals vertebral defects have also been reported (Mansour
et al., 2012). Mutation in FAT4 has also been shown to be
responsible in a subset of Hennekam syndrome patients (Alders
et al., 2014). The prime feature of Hennekam syndrome is congenital
lymphedema and lymphangiectasia, but some individuals also have
features overlapping with Van Maldergem syndrome.
Fat4 and Dchs1 are the vertebrate orthologs of Drosophila Fat
and Dachsous (Ds), respectively, which, together with the novel
Golgi kinase Four-jointed (Fj), regulate planar cell polarity (PCP)
and growth via the Hippo pathway (Staley and Irvine, 2012; Matis
and Axelrod, 2013). PCP is classically described as the coordinated
cell polarity within an epithelium, but in vertebrates has also been
shown to control cellular rearrangements and behaviours within
mesenchymal tissues (Goodrich and Strutt, 2011). The Hippo
pathway includes the Hippo (Mst1/2, or Stk4/3) andWarts (Lats1/2)
kinases, which act through the transcriptional co-factor Yorkie
(Yap/Taz) (Yu and Guan, 2013). InDrosophila, when Fat signalling
is active, the transcriptional co-factor Yorkie is phosphorylated and
retained in the cytoplasm where it is inactive. In the absence of Fat,
Yorkie is dephosphorylated and moves to the nucleus, where it
binds to the transcription factor Scalloped to promote cell
proliferation and survival. Ds can also directly regulate Hippo
signalling, but in this case Fat-to-Ds signalling inhibits the Hippo
kinase, resulting in the activation of Yorkie (Degoutin et al., 2013).
There is evidence that Fat-Ds regulation of both the Hippo and
PCP pathways is conserved in vertebrates. Fat regulation of PCP has
been clearly demonstrated in the kidney, hindbrain and sternum.
Fat4−/− mutants show defects in orientated cell divisions in the
extending kidney tubules (Saburi et al., 2008), and Fat4 and Dchs1
are essential for the collective neuronal polarity and migration of
facial branchiomotor neurons within the hindbrain (Zakaria et al.,
2014). Fat-PCP also controls cell intercalation movements during
the early development of the sternum (Mao et al., 2016).
In mammals, Fat4 regulation of the Hippo pathway has been
implicated in the cerebral cortex and kidney (Cappello et al., 2013;
Das et al., 2013). In the cerebral cortex, loss of Fat4 and Dchs1 is
associated with increased neuronal proliferation and increased
nuclear Yap/Taz activity (Cappello et al., 2013). Fat4 regulation of
Yap intracellular localisation within the pre-nephrogenic precursors
has also been observed (Das et al., 2013). However, other studies
have reported that Fat4 does not regulateYap localisation and activity
in the kidney (Mao et al., 2015; Bagherie-Lachidan et al., 2015).
We have previously reported that in Fat4 and Dchs1 mouse
mutants the lumbar vertebrae are malformed, which may beReceived 16 September 2015; Accepted 11 May 2016
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consistent with the vertebral defects reported in humans (Mao et al.,
2011; Mansour et al., 2012). The vertebrae in P0 Fat4 and Dchs1
mutants are also wider, raising the possibility that Fat-PCP alters the
relative dimensions of the vertebrae during early development.
Vertebrae, together with axial muscles and tendons, arise from the
epithelial somites, which are produced sequentially and regularly
from the pre-somitic mesoderm (Hubaud and Pourquie, 2014).
In response to Shh and Bmp antagonists from the adjacent tissues,
the ventral somite undergoes an epithelial-to-mesenchymal
transformation to form the sclerotome (Fan and Tessier-Lavigne,
1994; Johnson et al., 1994; Hirsinger et al., 1997; McMahon et al.,
1998; Stafford et al., 2011). The sclerotomal cells express Sox9, a
marker of chondrogenic commitment, and subsequently migrate to
surround the dorsal neural tube and notochord, forming the neural
arches and the vertebral body of the vertebrae, respectively.
Vertebral development requires the precise integration of several
signalling cascades, including Notch, FGFs, Shh, Wnt and Bmps
(Murtaugh et al., 1999; Maroto et al., 2012; Hubaud and Pourquie,
2014; Wahi et al., 2016). Here, we determine the role of Fat4 and
Dchs1 signalling during vertebral development and whether these
effects are mediated through alterations in the Hippo pathway or
PCP. We show a crucial role for Fat4-Dchs1 signalling during the
regulation of sclerotome proliferation that is independent of Yap
and Taz.
RESULTS
Fat4 and Dchs1 control vertebral development
Our previous analysis revealed that development of the thoracic and
lumbar vertebrae is affected inDchs1 and Fat4mousemutants (Mao
et al., 2011). There is a clear split in the midline of lumbar and
posterior thoracic vertebrae and some vertebrae are also fused along
the anterior-posterior axis (Fig. 1A-C) (Mao et al., 2011). To fully
understand the severity of the defects and how they occur, we first
examined each of the vertebrae in P0 wild type and Dchs1−/− and
Fat4−/− mutants. In thoracic vertebrae T6-13 and lumbar vertebrae
L1-L5 the vertebral body is wider and flatter, typically with dual
ossification centres. Patterning and identity of the vertebrae are not
affected and the lamina and transverse processes are present,
although the spinous process of T8 is bifid (Fig. 1). The more rostral
vertebrae are normal. No vertebral defects were observed in
heterozygous mice.
To analyse the severity of the defects in each vertebra, and if
particular vertebrae are more affected than others, we determined
whether they were split and/or fused across the anterior-posterior
axis. Vertebrae were also imaged from the dorsal side, and the shape
(form factor) of the ossification centres in wild type, Fat4−/− and
Dchs1−/− mutants was compared. Form factor is calculated as
4×π×area/perimeter2 and equals 1 for a circle. The split vertebrae
were given a score of 0. We found that the pattern and severity of the
defects in particular vertebrae varied between individual mutants,
but L2-L4 were the most frequently affected, i.e. split across the
midline and/or fused across the anterior-posterior axis (Fig. 1E,
Table S1). The range and severity of defects within the lumbar
vertebrae are very similar in Fat4−/− and Dchs1−/− mutants
indicating that, here, they operate as a receptor-ligand pair
(Fig. 1A-C,E, Table S1).
InDrosophila, Fat, Ds and Fj operate as a signalling cassette, and
in fat mutants Fj expression is increased (Yang et al., 2002).
Likewise, expression of Fjx1, the mammalian Fj homologue, is
increased in the kidneys of Fat4 mutants (Saburi et al., 2008). Fjx1
is expressed in the developing vertebrae in regions of Fat4 and
Dchs1 expression (Fig. 2A-F) (Rock et al., 2005), raising the
possibility that increased levels of Fjx1 might contribute to the
vertebral phenotype in Dchs1−/− and Fat4−/− mutants. To examine
this, we analysed vertebral development in Dchs1−/−;Fjx1−/−
double mutants. We found that simultaneous loss of Fjx1 neither
rescues the vertebral abnormalities nor enhances their severity in
Dchs1−/−mutants (Fig. 1D,E; n=3), consistent with an independent
study that compared Fat4−/− and Fat4−/−;Fjx1−/− mutants (Saburi
et al., 2012).
The sclerotome is specified appropriately in Fat4 and Dchs1
mutants
The sclerotome is specified at E9.5 and gives rise to the anlagen of
the vertebral body by E12.5. To understand potential mechanisms,
and when Fat4 and Dchs1 may control development of the
vertebrae, we analysed the expression of Fat4 and Dchs1 between
E10.5 and E13.5 by in situ hybridisation towhole-mounts and tissue
sections. We have previously shown that Fat4 and Dchs1 are
expressed in the early sclerotome at E9.5 (Mao et al., 2011). We
found that Fat4 and Dchs1 are still present throughout the
Fig. 1. Characterisation of vertebral defects in Fat4 and Dchs1 mouse
mutants. (A-D) Ventral view of the lumbar and posterior thoracic vertebrae of
P0 skeletons of the indicated genotypes stained with Alcian Blue and Alizarin
Red. Lumbar vertebrae are numbered. The panels beneath show individual
vertebrae: T, thoracic; L, lumbar. (E) Form factors of individual vertebrae in the
wild type and mutants. Each symbol indicates an individual mouse. The lower
the form factor the more the shape of the ossification centre within the vertebra
deviates from a perfect circle. A split vertebra, i.e. a vertebra with dual
ossification centres, has a score of 0. na, neural arch; l, lamina; p, pedicle; tp,
transverse process; sp, spinous process; vb, vertebral body.
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sclerotome at E10.5 (Fig. 2A,B), but by E11.5 they are expressed at
higher levels along the dorsoventral midline and the lateral edges of
the developing vertebral body (Fig. 2D,E). By E13.5, Fat4 and
Dchs1 are expressed in the cells around the differentiating vertebral
chondrocytes (data not shown) (Rock et al., 2005). These expression
data indicate that the vertebral defect most likely arises during the
early steps of sclerotome development and morphogenesis between
E9.5 and E12.5.
To determine if the vertebral defects are due to an alteration in
factors that are crucial for sclerotome development, we carried out
whole-mount in situ hybridisation of E10.5 and/or E11.5 embryos.
Specifically, we analysed the expression of the transcription factors
Pax1, Pax9, Bapx1 (Nkx3-2), Meox1 and Meox2. We also
determined the expression of Uncx4.1 (Uncx) and Tbx18, which
specify the posterior and anterior regions of the developing
sclerotome, respectively (Mansouri et al., 2000; Bussen et al.,
2004). All these genes were found to be expressed in their normal
domains (Fig. 2G-X, Fig. 3Q-T, Fig. S1). The data indicate that the
somites and sclerotome are specified appropriately, and that the
sclerotome is not obviously smaller at E10.5. The data also rule out
the possibility that potential alterations in the segmentation clock
contribute to these defects.
To determine if there are more subtle changes in the expression of
these somitic markers, and to quantify their expression, we carried
out qPCR of E10.5 lumbar and posterior thoracic somites. Here, as a
control, we also included Pax3, which is essential for the
development of the myogenic lineage (Tajbakhsh et al., 1997).
We found no significant change in the expression levels of these
markers (Fig. S2). These data again indicate that dysregulation of
these transcription factors is unlikely to contribute to the vertebral
defects and also indicate that the transcriptional network between
Bapx1, Pax1 and Pax9, which drives chondrocyte commitment, is
intact (Fig. S2).
Early morphogenesis of the vertebrae is affected in Fat4 and
Dchs1 mutants
The above analyses showed that early sclerotome development
occurs normally in Fat4 and Dchs1 mouse mutants. To determine
when the midline defect arises, we made skeletal preparations and
performed histological and immunolocalisation analyses at E10.5-
E14.5. Histological analysis showed that in Dchs1−/− and Fat4−/−
embryos the sclerotomal cells had started to condense around the
notochord at E11.5, but by E12.5 the sclerotomal cells appeared to
be more disorganised (Fig. 3E-H). The vertebrae were clearly split
by E13.5 (data not shown; Fat4−/−, n=3) and by E14.5 some
vertebrae were fused along the anterior-posterior axis (Fig. 3A,B for
E15.5; data not shown; Dchs1−/−, n=2; Fat4−/−, n=7).
To determine if the sclerotomal cells differentiate appropriately,
we analysed the expression of Sox9, which marks chondrogenic
precursors and committed chondrocytes (Lefebvre and Bhattaram,
2010), by immunolocalisation between E10.5 and E12.5. This
revealed the presence of Sox9-expressing cells throughout the
sclerotome at E10.5 (Fig. 3I,J) and E11.5 (Fig. 3K,L), but by E12.5
a subset of cells at the midline did not express Sox9 in Fat4 and
Dchs1 mutants (Fig. 3U,V; data not shown). The developing
sclerotome was also found to be significantly narrower along the
dorsoventral axis of the developing vertebral body at E11.5 and
E12.5 (Fig. 3U,V,X; P<0.001). We also analysed the expression of
collagen type II, a direct target of Sox9 (Lefebvre and Bhattaram,
2010), by in situ hybridisation (E10.5 and E11.5) and
immunolocalisation (E11.5) to determine potential alterations in
early chondrocyte differentiation. We found that collagen type II
is expressed normally (Fig. 3M-P; E10.5, Fat4−/−, n=2; E11.5,
Fat4−/−, n=6; E11.5, Dchs1−/−, n=3). As the vertebrae are fused
across the anterior-posterior axis, we also analysed the development
of the intervertebral disc. Histological analysis of E13 embryos
showed that the intervertebral discs are initially formed
appropriately (Fig. S3; n=6).
Fig. 2. Sclerotome specification is unaffected in Fat4 andDchs1mutants.
In situ hybridisation showing expression of Fat4 (A,D), Dchs1 (B,E) and Fjx1
(C,F) in the E10.5 (A-C) and E11.5 (D-F) wild-type sclerotome (arrows, A-C).
(G-X) Transverse sections (G-L,M,P,S,V) and lateral views (N,O,Q,R,T,U,W,X)
of in situ hybridisations of E10.5 wild-type/heterozygous (G-I,M-O,S-U),
Dchs1−/− (J,P,R,W) and Fat4−/− (K,L,Q,V,X) embryos showing expression of
the indicated genes. Arrows (G,J,M,P) indicate the developing sclerotome.
Dashed yellow lines outline one half of the developing vertebral body to show
the region of the sclerotome analysed for cell proliferation and apoptosis (A,D)
or the aorta (I,L,M,P) to show the sclerotomal expressionmore clearly. In N, the
forelimb (f ) and hindlimb (h) have been labelled to indicate the orientation of
the embryos in lateral views. nt, neural tube.
2369











The neural tube is wider in P0 Fat4 and Dchs1 mutants (Saburi
et al., 2008; Mao et al., 2011). To rule out the possibility that altered
neural tube development contributes to the development of the
hemivertebrae, we analysed skeletal preparations of E16.5
Vangl2Lp/Lp mice. The Vangl2Lp/Lp mutant is characterised by a
wide neural tube with a broad floor plate and also has vertebral
abnormalities (Greene et al., 1998; Stein and Mackensen, 1957).
Consistent with previous analysis, we found that the lumbar
vertebral bodies are not split, although a few split anterior thoracic
vertebrae that are also fused along the anterior-posterior axis were
observed (Fig. 3D; data not shown) (see also Greene et al., 1998;
Stein and Mackensen, 1957).
To confirm that Fat4-Dchs1 signalling acts intrinsically within
the mesoderm and that the vertebral defects are not secondary to
altered neural tube development, we generated Dermo1CreFat4f/f
mutants to inactivate expression within the mesoderm. We found
that the Dermo1CreFat4f/f mice are also characterised by
hemivertebrae, demonstrating an intrinsic requirement for Fat4
and Dchs1 within the mesoderm (Fig. S4).
Cell polarity is unaffected in Fat4 and Dchs1 mutants
The previous analyses indicated that the sclerotome is specified
appropriately but that it is narrower along the dorsoventral axis of
the developing vertebral body at E11.5. This might be due to
alterations in cell migration/rearrangements, survival or
proliferation. As Fat-Ds controls polarised cell arrangements in
Drosophila and mammals, and vertebral defects are also found in
Vangl2Lp/Lpmutants, we next addressed the possibility that Fat4 and
Fig. 3. Fat4 and Dchs1 are required for establishment
of the early vertebrae. (A-D) Dorsal views of Alcian Blue
and Alizarin Red stained E15.5 (A,B) and E16.5 (C,D)
wild-type (A,C), Dchs1−/− (B) and Vangl2Lp/Lp (D)
embryos. A fused vertebra along the anterior-posterior
axis is arrowed in B. (E-H) H&E (E,F) or Mallory’s triple
(G,H) stained transverse tissue sections through the
developing vertebrae of E11.5 (E,F) and E12.5 (G,H) wild
type (E,G) and Fat4−/− mutants (F,H).
(I-L,U,V) Immunostaining of Sox9 (blue in I-L,
yellow/white in U,V) and active caspase 3 (red in I,J) or
phospho-histone H3 (pH3) (red/pink in K,L) of E10.5 (I,J),
E11.5 (K,L) and E12.5 (U,V) wild-type (I,K,U), Fat4−/−
(J,L) and Dchs1−/− (V) developing lumbar vertebral
bodies. Arrows (I,J) indicate apoptotic cells; the
notochord is outlined by a yellow dashed line.
(M,N,Q-T) In situ hybridisations showing the expression
of collagen type II (M,N), Bapx1 (Q,R) and Pax9 (S,T) in
the developing vertebral body of heterozygous (M,Q,S),
Fat4−/− (N,R) and Dchs1−/− (T) E11.5 embryos.
(E-T) Dorsal is uppermost. (O,P) Immunostaining of
collagen type II expression in wild-type (O) and Fat4−/−
(P) E11.5 embryos. (X) The relative width across the
dorsoventral axis at E11.5 and E12.5 of the developing
lumbar vertebral body of Fat4−/− and Dchs1−/− embryos
as compared with wild-type/heterozygous littermates.
(Y) The relative percentage of proliferating cells as
determined by pH3 immunostaining at E10.5 and E11.5;
the percentage proliferation in wild-type/heterozygous
embryos is standardised to 100%. (Z) The relative
percentage of apoptotic cells as determined by
immunostaining for active caspase 3 at E10.5 and E11.5;
the percentage apoptosis in wild-type/heterozygous
embryos is standardised to 100%. Mean plus s.d.
*P<0.05, **P<0.005, ***P<0.001. a, anterior; d, dorsal; n,
notochord; p, posterior; v, ventral.
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Dchs1 might control polarised cell behaviours during vertebra
formation.
Cell orientation and polarity were determined at E10.5, a time
point when sclerotomal cells are starting to surround the notochord
and just prior to the formation of the narrower sclerotome at E11.5.
First we determined the orientation of the long axis of the nucleus,
the shape of the nuclei and the collective organisation of cells within
the sclerotome. Second, the angle of the Golgi complex relative
to the mediolateral axis of the embryo was measured.
Analysis of cell orientation indicated that in wild-type
embryos (n=7) the sclerotomal cells are collectively polarised
(Fig. 4A,A′,C,C′; P<0.001). The sclerotomal cells are also
polarised in Fat4−/− (n=4; P=0.031) and Dchs1−/− (n=4;
P=0.00003) embryos and there is no significant difference in
the degree of polarisation compared with wild-type embryos
(Mardia-Whatson-Wheeler test; P=0.245 for Fat4−/− versus wild
type and P=0.284 for Dchs1−/− versus wild type). Furthermore,
the length of the mean vector, which indicates how closely the
observations are clustered around the mean value of the angle,
was analysed. We again found no differences in the overall
organisation and alignment of nuclei between wild-type, Fat4−/−
(P=0.0954) and Dchs1−/− (P=0.4507) embryos (Fig. 4F). We
also examined the relative shape and elongation of nuclei, which
is presented as a ratio of the longer to shorter axis of the nucleus
(the aspect ratio). The aspect ratio averaged 1.65 for wild-type,
1.64 for Fat4−/− and 1.69 for Dchs1−/− embryos and, therefore,
no differences in cell shape (as indicated by nuclear shape) were
identified (Fig. 4E).
Analysis of the position of the Golgi apparatus revealed far more
variation and less coordinated polarity compared with the
orientation of the nuclei. However, there was significant bias and
the Rayleigh uniformity test reported P<0.05 for both wild-type and
mutant embryos. This indicates that although the distribution of
angles is not uniform and there is a large variation, a clear bias can
be observed. Again no difference in the bias/overall polarity of the
Golgi apparatus was detected between wild-type, Fat4−/−
(P=0.245) and Dchs1−/− (P=0.284) embryos (Fig. 4A″-D″).
Fat4 and Dchs1 regulate proliferation within the developing
sclerotome
The above studies showed that the developing vertebral body is
thinner across the dorsoventral axis at E11.5 and splits by E13.5, but
there are no alterations in cell polarity. To examine if changes in cell
mitosis and apoptosis contribute to the vertebral defects, we carried
Fig. 4. Cell polarity analysis within the developing sclerotome. (A-D) Transverse sections through E10.5 wild-type (A,C), Fat4−/− (B) and Dchs1−/− (D)
developing lumbar vertebrae showing immunostaining of Sox9 (blue) and the Golgi (red). Boxes (A,B) indicate the region of the sclerotome analysed, as
shown at higher magnification in the insets. Arrows (A) indicate the angle of the Golgi complex. Lines (B) show the direction of the long axis of the nuclei.
(A′-D′) Rose plots of nuclear alignment, where 0-180° is the alignment across the mediolateral axis of the embryo. (A″-D″) Orientation of the Golgi complex in the
sclerotome relative to the mediolateral axis of the embryo. (E) The relative elongation of nuclei within the sclerotome, presented as a ratio of the longer to shorter
axis of the nucleus (the aspect ratio). (F) The length of the mean vector, which indicates how closely the observations are clustered around the mean value of the
angle. WT, wild type; DCHS1, Dchs1−/−; FAT4, Fat4−/−. Mean+s.e.m.
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out immunolocalisation of phospho-histone H3 (pH3) and activated
caspase 3. In E10.5 heterozygous/wild-type controls, pH3 staining
ranged between 1.2% and 3.1% (n=10), whereas in the Fat4−/− and
Dchs1−/− mutants this proliferation marker ranged between 0.76%
and 2.67% (Dchs1−/−, n=5; Fat4−/−, n=3). Proliferation was
consistently decreased in the mutant compared with heterozygous/
wild-type littermates. This decrease was significant at E10.5 and
E11.5 in both Fat4−/− and Dchs1−/− mutants when compared with
the control embryos (Fig. 3Y; E10.5, Dchs1, n=5, P<0.005; E10.5,
Fat4, n=3, P<0.01; E11.5, Dchs1, n=4, P<0.005; E11.5, Fat4, n=6,
P<0.005).
A significant reduction in the number of apoptotic cells was also
seen in Fat4−/−, but not Dchs1−/−, mutants when compared with
wild-type/heterozygous littermates (Fig. 3Z; P<0.01). The
percentage of apoptotic cells ranged between 1.2% and 2.7% in
control embryos and between 0.69% and 2.15% in mutant embryos
at E10.5 (Fig. 3Z). At E11.5, the levels of apoptosis were very
similar between wild-type and mutant embryos, averaging 1.22%
for control embryos versus 1.06% for Dchs1mutants and 0.68% for
controls versus 0.73% for Fat4 mutants (n=3 for each). Therefore,
decreased cell mitosis, and not increased cell death, contributes to
the narrowing of the sclerotome in Fat4−/− and Dchs1−/− embryos.
Fat4 and Dchs1 do not regulate Yap/Taz activity in the
developing vertebrae
Fat signalling regulates Yorkie in Drosophila and Fat4-Dchs1 has
also been reported to inhibit Yap/Taz activity in mammals
(Cappello et al., 2013; Das et al., 2013). In Drosophila fat
mutants, the growth phenotype can be rescued by simultaneous
knockdown of yorkie (Reddy and Irvine, 2008). Likewise, in mice
knockdown of Yap rescues the neuronal proliferation defects caused
by reduction in Fat4 and Dchs1 expression (Cappello et al., 2013).
To determine any potential genetic interaction between Fat4/Dchs1
and Yap (Yap1)/Taz (Wwtr1), we analysed the form factor of
individual vertebrae in P0 Fat4−/−;Taz−/−, Fat4−/−;Taz+/− and
Fat4−/−;Yap+/− mutants. This revealed that neither homozygous/
heterozygous loss of Taz nor heterozygous loss of Yap can rescue
the severity and range of posterior thoracic and lumbar vertebral
defects in Fat4−/− mutants (Fig. 5A-J). Instead, the defects were
extended to include the anterior thoracic vertebrae, which were
smaller and malformed, particularly in Fat4−/−;Taz−/− double
mutants (Fig. 5B,D). L6 was also affected in two of four Fat4−/−;
Yap+/− mice.
Another possibility raised by the identification of Fat-to-Ds
activation of Yorkie in Drosophila (Degoutin et al., 2013), is that
Dchs1 acts as the receptor and that loss of Fat4-to-Dchs1 signalling
decreases Yap/Taz activity. This decreased activity could be
expected to be responsible for decreased sclerotomal proliferation.
To test this potential link genetically, we analysed vertebral
development in Fat4+/−;Taz+/− and Fat+/−;Yap+/− P0 mice.
However, we found that vertebral development was normal
(Fig. 5A,C). The expression of the Yap/Taz target Ctgf in E10.5
mutant somites was also analysed by qPCR and found to be similar
to wild-type levels (Fig. S2). Together, the data indicate that
decreased Yap or Taz activity alone is unlikely to contribute to the
vertebral defects in Fat4−/− and Dchs1−/− mutants.
DISCUSSION
The Fat4-Dchs1 pathway is crucial for the development of many
organs, but in general the cellular and intracellular signalling
mechanisms that are regulated by Fat4-Dchs1 are unknown. Based
on potential conservation between Drosophila and mammals it has
Fig. 5. Loss of Yap or Taz does not rescue the Fat4−/−
vertebral defects. (A-H) Alcian Blue and Alizarin Red
staining of P0 thoracic (A-D) and lumbar (E-H) vertebrae of
mice of the indicated genotypes. In Fat4−/−;Yap+/− and
Fat4−/−;Taz−/− mice, some of the anterior thoracic vertebrae,
which are normal in Fat4−/− mice, are now also affected
(arrowed). (I,J) Form factors of vertebrae T8-L6 of mice of the
indicated genotypes. Each symbol indicates an individual
mouse.
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been proposed that Fat4-Dchs1 regulates PCP and the Hippo
pathway. Conservation of PCP has clearly been shown in the
hindbrain and kidney but conservation of Fat4-Hippo signalling is
controversial (Cappello et al., 2013; Das et al., 2013; Zakaria et al.,
2014; Mao et al., 2015; Bagherie-Lachidan et al., 2015). We have
previously reported that Fat4 and Dchs1 mutants are characterised
by wider vertebrae that are also fused along the anterior-posterior
axis, raising the possibility that alterations in polarised cell
behaviours contribute to this phenotype (Mao et al., 2011). We
find, however, that cell polarity is unperturbed and that the early
sclerotome is specified appropriately. Instead, Fat4-Dchs1
signalling acts cell-autonomously within the somitic mesoderm to
regulate cell proliferation at E10.5 and E11.5, time points when cell
proliferation and sclerotomal expansion are at their highest (Gasser,
1979). In the absence of Fat4 or Dchs1, the developing vertebral
body anlagen is smaller and at the midline does not reach the critical
size to condense appropriately. Despite the altered cell proliferation,
we find no evidence of Fat4-Dchs1 regulation of Yap/Taz activity,
suggesting novel mechanisms of Fat4-Dchs1 signalling.
Vertebral development involves complex signalling interactions
that must be regulated both temporally and spatially to first specify
the somites from the presomitic mesoderm in a regular manner and
then to specify the somite into its various somitic cell lineages,
including chondrocytes, muscle and dermis (Maroto et al., 2012).
Here, we have added another signalling pathway to this network,
namely the Fat4-Dchs1 signalling pathway, which is essential for
vertebral development in mice and humans (our data; Mansour
et al., 2012). In Fat4 and Dchs1 mutants, the vertebrae are
narrower along the dorsoventral and anterior-posterior axes. They
are also split at the midline and are fused along the anterior-
posterior axis. The neural arches are unaffected. These defects
resemble the vertebral anomalies that occur in the absence of Pax1,
Pax9, Meox1/Meox2 and Bapx1, a transcriptional network that
promotes sclerotome cell proliferation and drives chondrogenesis
(Wallin et al., 1994; Lettice et al., 1999; Murtaugh et al., 1999;
Peters et al., 1999; Tribioli and Lufkin, 1999; Mankoo et al., 2003;
Rodrigo et al., 2003). This transcriptional complex and the
regulatory network that drives Sox9 expression and differentiation
appear to be intact in Fat4 and Dchs1 mutants. Although we
cannot rule out later roles of Fat4/Dchs1 in the maintenance of
chondrocyte identity, the early role of Fat4-Dchs1 signalling
during vertebral development is in contrast to the role of the related
proteins Fat3 and Dchs2 in the developing pharyngeal cartilages of
zebrafish. In the pharyngeal cartilages, Fat3-Dchs2 have been
shown to control chondrocyte development via the regulation of
Sox9a (Le Pabic et al., 2014). Downregulation of either Fat3 or
Dchs2 results in decreased Sox9a expression and the failure of the
developing chondrocytes to intercalate appropriately, ultimately
resulting in dysmorphic pharyngeal cartilages (Le Pabic et al.,
2014).
The key defect in mouse Fat4 andDchs1mutants is the reduction
in the number of sclerotomal cells due to decreased cell
proliferation, although it is possible that there are also minor
changes in sclerotomal specification that might contribute to the
formation of a smaller vertebral body. Fat4 andDchs1 are expressed
in the sclerotome between E9.5 and E11.5 (Mao et al., 2011; this
study). The decreased proliferation at E10.5 results in a smaller
sclerotome at E11.5, and cells at the centre of the developing
vertebrae do not reach the critical cell mass for chondrogenesis to
proceed around the notochord (Hall and Miyake, 2000). As a
consequence, two cartilage condensations develop adjacent to the
notochord and the vertebral bodies are split.
In both Drosophila and mammals, loss of Fat signalling has been
linked to increased Yorkie and Yap/Taz signalling and knockdown
of Yorkie, Yap or Taz in Drosophila and the mammalian cerebral
cortex can rescue the defects that result from the loss of Fat/Fat4
signalling (Reddy and Irvine, 2008; Cappello et al., 2013). Analysis
of Fat4−/−;Taz−/−, Fat4−/−;Taz+/− and Fat4−/−;Yap+/− double
mutants suggests that the vertebral defects are not mediated by
increased Yap/Taz signalling. In fact, in Fat4−/−;Taz−/− and, to a
lesser extent, in Fat4−/−;Yap+/− double mutants the vertebral defects
are extended to encompass the anterior thoracic vertebrae,
suggesting that they operate in parallel pathways. This lack of
interaction between Fat4 and Yap/Taz has also been observed in the
kidney (Mao et al., 2015; Bagherie-Lachidan et al., 2015),
indicating distinct mechanisms of Fat4-Dchs1 signalling during
vertebrate development. Indeed, there is currently very little, if any,
evidence of a direct link between Fat4 and Hippo signalling in
vertebrates. How Fat4 might regulate Yap/Taz activity is also
unclear, as the intracellular region of Fat4 either lacks or shows
limited sequence conservation in the domains that are crucial for
Fat-Hippo signalling in Drosophila (Bossuyt et al., 2014).
Consistent with this limited homology, the intracellular domain of
human FAT4 can rescue the PCP, but not the growth, defects in
Drosophila fat mutants (Pan et al., 2013).
As Ds has been shown to act cell-autonomously as a receptor to
increase Yorkie signalling inDrosophila (Degoutin et al., 2013), we
also considered the reverse possibility that there is decreased Yap/
Taz activity in Fat4−/− or Dchs1−/− mouse mutants. This decreased
Yap/Taz activity would be anticipated to result in decreased cell
proliferation, consistent with our data. However, neither Taz−/−,
Yap+/−, Fat4+/−;Taz+/− or Fat4+/−;Yap+/− mice have vertebral
defects. Also, expression of Ctgf, a direct transcriptional target of
Yap/Taz, is unaffected in Fat4 and Dchs1 mutants. Therefore, we
also conclude that loss of Yap/Taz signalling is unlikely to be
responsible for the vertebral malformations in Fat4 and Dchs1
mutants. It is not yet clear if Fat4/Dchs1 regulate cell proliferation
directly via a transcriptional mechanism and/or modulate the
activity of another signalling pathway required for cell proliferation,
such as Shh (Fan et al., 1995; Marcelle et al., 1999).
PCP classically controls cellular organisation across an epithelial
tissue. In vertebrates, the Fz-PCP pathway has also been shown to
control coordinated cellular behaviours within mesenchymal
tissues. Examples include cell intercalation during gastrulation,
cell orientation in the developing limb bud, and cell-to-cell
interactions within migratory neural crest streams (Goodrich and
Strutt, 2011; Gao and Yang, 2013; Mayor and Theveneau, 2014;
Sokol, 2015). As there are vertebral defects in both Fz-PCP and the
Fat4 and Dchs1 mutants, we considered the possibility that Fat4-
Dchs1 might regulate polarised cell behaviours and rearrangements
during sclerotomal morphogenesis. An alteration in how the cells
are organised could contribute to both the formation of the
hemivertebrae and the fusion of the vertebrae along the anterior-
posterior axis. The vertebrae of P0 Fat4 and Dchs1mutants are also
wider, which again raised the possibility that cells are not arranged
appropriately during early morphogenesis. We found that in wild-
type embryos the sclerotomal cells are polarised and the orientation
of the Golgi complex, another indicator of polarity, also reveals a
polarity bias. However, we found no evidence that this polarised cell
behaviour is disrupted in Fat4 and Dchs1mutants. The width of the
developing vertebral body at E10.5-E11.5 along the mediolateral
axis also appears to be initially the same in Fat4 and Dchs1mutants
when compared with wild-type embryos. The increased width of the
vertebrae and neural arches in P0 Fat4 and Dchs1mutants therefore
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occurs later and is secondary to changes in the development of the
split vertebral bodies and the increased width of the spinal cord
(Saburi et al., 2008; Mao et al., 2011).
Fat4-Dchs1 signalling controls the development of many organs in
both mice and humans, but in general the cellular mechanisms of Fat4
signalling are unknown. Fat/Fat4 regulation of cell behaviours through
PCP has been shown to be conserved (Saburi et al., 2008; Mao et al.,
2011, 2016; Zakaria et al., 2014). Evidence linking Fat4/Dchs1 to the
Hippo pathway is less clear (Cappello et al., 2013; Das et al., 2013;
Mao et al., 2015; Bagherie-Lachidan et al., 2015). Here we show that
Fat4-Dchs1 controls cell proliferation within the developing
sclerotome. This Fat4-Dchs1 promotion of cell proliferation has also
been observed in the kidneymesenchyme and ureteric distal tips (Mao
et al., 2011) and is in stark contrast to Fat4-Dchs1 inhibition of cell
proliferation in the cerebral cortex (Cappello et al., 2013).We conclude
that novel mechanisms of Fat4-Dchs1 signalling have evolved to
regulate cell proliferation, probably through a Hippo-independent
pathway. As with other signalling pathways, there are pleiotropic roles
for Fat4-Dchs1 signalling that range from the regulation of polarised
cell behaviours, proliferation and differentiation to cell survival
(Saburi et al., 2008;Mao et al., 2011, 2015; Cappello et al., 2013; Das
et al., 2013; Zakaria et al., 2014). Determining the exact roles of Fat4-
Dchs1 signalling during organogenesis and how these distinct cellular
outcomes are established will be essential to understand the basis of




The Fat4−/−, Dchs1−/−, Dchs1f/f, Fat4f/f, Taz−/− (Wwtr1−/−), Yapf/f and
Dermo1Cre (Dermo1 is also known as Twist1) mouse lines have been
described previously (Humphreys et al., 2010; Kobayashi et al., 2008; Mao
et al., 2011, 2015; Saburi et al., 2008; Yu et al., 2003). Noon of the day of the
vaginal plug was assigned E0.5. DNA was isolated using Direct PCR-Ear
Lysis Reagent (PeqLab) or the Promega Hot Start 2 Kit and genotyping was
performed as previously described (Mao et al., 2011). All mouse procedures
were approved by the IACUC either at Rutgers University or King’s College
London in agreement with established guidelines for animal care.
Histology and immunohistological analyses
Embryos were fixed overnight in 4% paraformaldehyde and processed into
wax. Sections (10 µm) through the developing lumbar vertebrae were stained
with either Haematoxylin and Eosin (H&E), Mallory’s triple stain or
immunostained with primary antibodies anti-Sox9 (rabbit, Millipore,
AB5535, 1:400; or goat, Santa Cruz, SC-17341, 1:50), rabbit anti-human
cleaved caspase 3 (Cell Signaling Technology, 9661S, 1:200), mouse anti-
phospho-Ser10 histone H3 (Millipore, 9706S, 1:100), rabbit anti-Golgi
(Abcam,24586,1:100) orcollagen type II (Abcam, ab34712, 1:200) following
antigen retrieval in citrate buffer. The region of the developing vertebral body
analysed is indicated by the dashed yellow lines in Fig. 2A,D and is shown by
the Sox9 immunostaining in Fig. 3I-L. At least six sections from each embryo,
60 µm apart, or all sections spanning L4-T12 were analysed.
For the apoptosis analysis at least 870 cells were analysed (range 870-
6000/embryo at E10.5 and at least 2000-9000 cells/embryo at E11.5). The
total number of cells analysed were as follows: E10.5, Dchs1+/+ 14,510,
Dchs1−/− 16,326, Fat4+/+ 8074, Fat4−/− 5699; E11.5, Dchs1+/+ 12,162,
Dchs1−/− 10,758, Fat4+/+ 40,491, Fat4−/− 24,942. For the proliferation
analysis, at least 500 cells were counted (range 523-9844 at E10.5 and at
least 2000-9844 at E11.5). The total number of cells analysed were
as follows: E10.5, Dchs1+/+ 15,277, Dchs1−/− 13,196, Fat4+/+ 11,339,
Fat4−/− 7182; E11.5, Dchs1+/+ 12,162, Dchs1−/− 10,758, Fat4+/+ 57,919,
Fat4−/− 45,718. The following numbers of mutant embryos were analysed
and compared with wild-type/heterozygous littermates: pH3 at E10.5, Fat4
n=3, Dchs1 n=7; pH3 at E11.5, Fat4 n=6, Dchs1 n=4; active caspase 3 at
E10.5, Fat4 n=3, Dchs1 n=4; active caspase 3 at E11.5, Fat4 n=3, Dchs1
n=4; collagen type II at E11.5, Fat4 n=2, Dchs1 n=2. Skeletal staining was
performed as described by Huang et al. (2002).
In situ hybridisation
In situ hybridisation was performed on 10 µm sections of
paraformaldehyde-fixed tissue processed into wax or whole embryos
according to standard protocols, using DIG-labelled probes. Embryos were
processed in 20% gelatin in PBS for vibratome sectioning (40 µm). The
following numbers of embryos were analysed: E10.5, for Pax1, Fat4 n=3,
Dchs1 n=3; for Pax9, Fat4 n=3, Dchs1 n=4; for Bapx1, Fat4 n=3, Dchs1
n=3; for Meox1, Fat4 n=2, Dchs1 n=2; for Meox2, Fat4 n=3, Dchs1 n=2;
for Tbx18, Fat4 n=2, Dchs1 n=2; for Uncx4.1, Fat4 n=3, Dchs1 n=2; for
collagen type II, Fat4 n=2; E11.5, for Pax9, Fat4 n=3, Dchs1 n=1; for
Bapx1, Fat4 n=3, Dchs1 n=2; for collagen type II, Fat4 n=4, Dchs1 n=1.
qPCR analysis
RNAwas isolated from lumbar and posterior thoracic somites of E10.5 wild-
type, Dchs1−/− and Fat4−/− embryos using TRIzol Reagent (Invitrogen)
according to the manufacturer’s instructions. cDNA was prepared from
200 ng total RNA as a template using the Precision nanoScript Reverse
Transcription Kit (Primer Design). qPCR for mRNA expression was
performed in triplicate using Precision Real-Time PCR MasterMix with
SYBR Green (Primer Design) according to the manufacturer’s instructions.
Primers were designed using Primer-BLAST (NCBI) (see Table S1). qPCR
was performed and results analysed using a Qiagen Rotor-Gene Q machine
and software package. Data were quantified by the ΔΔCT method using
Gapdh as a control. Significance of the datawas analysed by Student’s t-test.
Image analysis and statistics
Immunolocalisation images were collected using a laser-scanning confocal
microscope (Leica) and analysis performed using AxioVision (Zeiss) for
Golgi orientation and CellProfiler 2.0 (Broad Institute) for nuclei
parameters. Circular analysis of Golgi complex orientation and nuclear
alignment was performed using Oriana4.0 (Kovach) (Rayleigh uniformity
test and Mardia-Whatson-Wheeler nonparametric test). Graphs were
prepared and linear statistical analysis performed using GraphPad (Prism).
P0 skeletons stained with Alcian Blue and Alizarin Red were imaged from
the ventral side and individual vertebral bodies segmented using CellProfiler
2.0. For each vertebral body, a form factor was automatically calculated as
4×π×area/perimeter2. Form factor equals 1 for a perfectly circular object,
while 0 was assigned for split vertebral bodies.
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